Clinical trials
Varicella (Chickenpox) clinical trials
Below are recruiting varicella (chickenpox) clinical trials, each written for real people, not researchers. We’re tracking 7 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07475000RecruitingPhase 3
Second chickenpox vaccine for healthy children
This trial is testing a second dose of the chickenpox vaccine in healthy children who already received one dose. It aims to see if a booster dose provides better protection.
AkdenizAges 1.3 years–12 years - NCT07054099RecruitingPhase 3
Testing a chickenpox vaccine for children ages 1 to 12
This study tests a new chickenpox vaccine (MG1111, also called BARYCELA Inj.) in healthy children aged 1 to 12 years. It checks how well the vaccine works and if it is safe, with two doses given over time.
Khon Kaen, Changwat Khon KaenAges 1–12 - NCT06693895RecruitingPhase 3
Chickenpox vaccine safety study for healthy toddlers
This study tests a new chickenpox vaccine for healthy children ages 12 to 15 months. It aims to see if the vaccine is safe and helps protect against chickenpox.
Phoenix, ArizonaAges 1 year–1.3 years - NCT06806137RecruitingPhase 3
Chickenpox vaccine study for healthy toddlers
This study tests how well a second dose of an investigational chickenpox vaccine works and how safe it is in healthy children. Your child would get the first dose between 12-15 months old, then a booster 3 months later.
Salvaleón de Higüey, La Altagracia ProvinceAges 1 year–1.3 years - NCT06855160RecruitingPhase 3
Chickenpox & MMR Vaccine Study for Healthy Toddlers
This study tests a new chickenpox vaccine combined with a standard MMR vaccine (measles, mumps, rubella) in healthy children aged 12-15 months. The goal is to see how well the vaccines work and how safe they are when given as a shot in the arm.
Tucson, ArizonaAges 1 year–1.3 years - NCT06740630RecruitingPhase 3
A chickenpox vaccine study for healthy toddlers 12 to 15 months old
This study tests an experimental chickenpox vaccine to see how well it works and if it's safe. Your child may be able to join if they are healthy and between 12 and 15 months old.
Mobile, AlabamaAges 1 year–1.3 years - NCT07406360RecruitingPhase 3
Combined MMR and chickenpox vaccine booster for children
This study tests a combined vaccine that protects against measles, mumps, rubella, and chickenpox (varicella) in one shot. It's for healthy children who have already had their first dose of chickenpox and MMR vaccines, to see if this booster is safe and works well.
Birmingham, AlabamaAges 1.3 years–6 years
Hear when a new Varicella (Chickenpox) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for varicella (chickenpox)?
- Yes. Clin2 currently lists 7 recruiting varicella (chickenpox) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a varicella (chickenpox) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a varicella (chickenpox) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.